High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction

Øyvind Ellingsen1, Martin Halle2, Viviane Conraads2

  • 1From St. Olavs Hospital, Trondheim University Hospital, Norway (Ø.E., A.S., H.D., V.V., T.K.); K.G. Jebsen Center for Exercise in Medicine, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway (Ø.E., H.D., T.K.); Department of Prevention, Rehabilitation and Sports Medicine, Technische Universität München, Klinikum rechts der Isar, Germany (M.H., J.W.C., A.P.); DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany (M.H.); Else-Kröner-Fresenius Prevention Center, Klinikum rechts der Isar, Munich, Germany (M.H.); Antwerp University Hospital, Edegem, Belgium (V.C., E.M.V.C., P.B.); University of Antwerp, Belgium (V.C., E.M.V.C., P.B.); Department of Circulation and Medical Imaging (A.S., T.H.) and Department of Laboratory Medicine, Children's and Women's Health (V.V.), NTNU-Norwegian University of Science and Technology, Trondheim, Norway; Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Norway (H.D.); Centre Hospitalier de Luxembourg, Luxembourg (C.D., P.F.); Department of Cardiology, Stavanger University Hospital, Norway (A.- I.L., T.V.); Department of Clinical Science, University of Bergen, Norway (A.-I.L., T.V.); Ålesund Hospital, Møre og Romsdal Health Trust, Norway (T.H.); Cardiac Rehabilitation Division, Salvatore Maugeri Foundation IRCCS, Scientific Institute of Veruno, Italy (A.M.); Division of Cardiovascular Medicine, Stanford Center for Inherited Cardiovascular Disease, CA (J.W.C.); Department of Cardiology, Herzzentrum, Universität Leipzig, Germany (E.W., N.M., F.W., R. Höllriegel, A.L.); Department of Cardiology, Bispebjerg Hospital, University of Copenhagen, Denmark (T.M.-H., M.S., E.P.); University of Oslo, Rikshospitalet University Hospital, Norway (J.K.); Department of Cardiology and Angiology, Klinikum Links der Weser, Bremen, Germany (R. Hambrecht); and Department of Cardiology, Angiology and Intensive Care, Klinikum Lippe, Detmold, Germany (S.G.). oyvind.ellingsen@ntnu.no.

Circulation
|January 14, 2017
PubMed
Summary

High-intensity interval training (HIIT) and moderate continuous training (MCT) did not differ in improving heart failure with reduced ejection fraction. Neither exercise improved cardiac remodeling or aerobic capacity long-term.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
491
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
446
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.8K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
505
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K